The Belrise Industries Limited has submitted to the Exchange statement of deviation & Variation for the quarter ended March 31, 2026.
BELRISE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Belrise Industries has submitted its Q4 FY2026 (quarter ended March 31, 2026) report on IPO fund utilization. The company raised Rs. 21,500 million (net proceeds Rs. 20,286.12 million) through its IPO in May 2025. There is NO deviation in the utilization of funds — the company has deployed funds largely as per the offer document. For debt repayment, Rs. 15,960.21 million was utilized (vs. original estimate of Rs. 16,181.27 million), fully completed in Q1 itself. General corporate purposes received Rs. 4,321.64 million of the Rs. 4,325.91 million allocated (Rs. 4.27 million remains). The small variation (debt repayment came in slightly lower than estimated) led to a corresponding increase in GCP allocation, within the flexibility permitted. Rs. 438.68 million remains unutilized, primarily for pending issue expenses. The Audit Committee reviewed the statement on May 15, 2026, with no comments or objections.
This is a routine compliance filing showing proper deployment of IPO proceeds as intended. There is no adverse deviation — the minor variation in debt repayment amount was absorbed by adjusting the GCP allocation within allowed limits. For shareholders, this confirms the IPO funds have been used for the stated purposes (debt reduction and general corporate use) with full transparency. The small unutilized balance relates to ongoing issue expense payments.